LQDA CIK: 1819576

Liquidia Corp

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
61.3
FY22:
99.8
FY23:
89.9
FY24:
185
FY25:
273
(positive)
Change from FY21 to FY25
millions USD
FY21:
32.5
FY22:
29.4
FY23:
28.4
FY24:
45.2
FY25:
54.5
Total assets
Change from FY21 to FY25
millions USD
FY21:
93.7
FY22:
129
FY23:
118
FY24:
230
FY25:
328

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
7.33
FY22:
8.80
FY23:
18.6
FY24:
41.8
FY25:
136
(negative)
Change from FY21 to FY25
millions USD
FY21:
21.1
FY22:
30.0
FY23:
52.5
FY24:
109
FY25:
147
(positive)
Change from FY21 to FY25
millions USD
FY21:
65.3
FY22:
90.4
FY23:
47.3
FY24:
79.4
FY25:
44.7
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
93.7
FY22:
129
FY23:
118
FY24:
230
FY25:
328

All amounts in millions USD Data source:SEC EDGAR